From: Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer
tumor volume (mm3)
apoptotic index (%)
proliferation index (%)
control
486.3 ± 25.3
1.5 ± 0.3
83.7 ± 3.3
paclitaxel
403.8 ± 36.3*
3.9 ± 0.9*
69.1 ± 4.8*
palitaxel + DHMEQ
160.8 ± 20.3*, **
10.0 ± 0.8*, **
34.3 ± 3.6*, **